Hours after President Trump said Sunday he had "second thoughts" about escalating the trade war with China, the White House sought to explain his remark because it was...Politicsread more
Clouding the G-7 gathering, which represents the world's major industrial economies, are the tit-for-tat tariffs between Washington and Beijing.Politicsread more
President Donald Trump said that he would have a major trade deal with U.K. after it leaves the European Union.Politicsread more
Despite Kudlow's expectations, China said on Saturday that it strongly opposes Trump's decision to levy additional tariffs on $550 billion worth of Chinese goods, and warned...Politicsread more
President Donald Trump said Sunday he was not happy after North Korea launched short-range ballistic missiles over the weekend.Politicsread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
The world's second biggest economy is past a point where it cannot ignore its enormous debt anymore, according to an analyst.China Economyread more
bln@ (Adds details on deal, shares)
Aug 7 (Reuters) - Private equity firm Permira Funds will buy Cambrex Corp for about $2 billion, the drug contract development and manufacturing company said on Wednesday.
The all-cash offer of $60 per Cambrex share represents a 47% premium to the stock's Tuesday close. The company's shares were trading at $59.20 before the bell on Wednesday.
Cambrex, which provides drug developers with manufacturing and testing services, said that the deal is expected to close during the fourth quarter.
Including debt, the deal is valued at about $2.4 billion.
The transaction will be financed through a combination of debt and equity financing, Cambrex said.
Morgan Stanley & Co LLC is the financial adviser, while Kirkland & Ellis LLP is the legal adviser to Cambrex.
RBC Capital Markets is the financial adviser to Permira funds, while Skadden, Arps, Slate, Meagher & Flom LLP is the legal adviser.
(Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Sriraj Kalluvila)